Document ID: chunk:federal_register_of_legislation:F2020L00500:reg:7
Version: federal_register_of_legislation:F2020L00500
Segment Type: reg
Provision Reference: reg 7
Character Range: 1689–3492

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about polyarteritis nodosa and death from polyarteritis nodosa.
Meaning of polyarteritis nodosa
(2)          For the purposes of this Statement of Principles, polyarteritis nodosa:
(a)          means a non-granulomatous necrotising arteritis predominantly affecting medium or small arteries; and
(b)          includes cutaneous polyarteritis nodosa and single organ polyarteritis nodosa; and
(c)          excludes:
                (i)            glomerulonephritis;
                (ii)         Kawasaki disease;
                (iii)       microscopic polyangiitis; and
                (iv)        polyangiitis overlap syndrome.
            Note: Polyarteritis nodosa is usually associated with an absence of antineutrophil cytoplasmic antibodies.
(3)          While polyarteritis nodosa attracts ICD‑10‑AM code M30.0, in applying this Statement of Principles the meaning of polyarteritis nodosa is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from polyarteritis nodosa
(5)          For the purposes of this Statement of Principles, polyarteritis nodosa, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's polyarteritis nodosa.
Note: terminal event is defined in the Schedule 1 – Dictionary.